Abstract
Background Pneumonia remains a leading cause of hospitalization and death among young children worldwide, and the diagnostic challenge of differentiating bacterial from non-bacterial pneumonia is the main driver of antibiotic use for treating pneumonia in children. Causal Bayesian networks (BNs) serve as powerful tools for this problem as they provide clear maps of probabilistic relationships between variables and produce results in an explainable way by incoporating both domain expert knowledge and numerical data.
Methods We used domain expert knowledge and data in combination and iteratively, to construct, parameterise and validate a causal BN to predict causative pathogens for childhood pneumonia. Expert knowledge elicitation occurred through a series of group workshops, surveys and one-on-one meetings involving 6-8 experts from diverse domain areas. The model performance was evaluated based on both quantitative metrics (area under the receiver-operating characteristics curve (AUROC) and log loss) and qualitative expert validation. Sensitivity analyses were conducted to investigate how the target output is influenced by varying key assumptions of particular high degree of uncertainty around data or domain expert knowledge.
Results Designed to apply to a cohort of children with X-ray confirmed pneumonia who presented to a tertiary paediatric hospital in Australia, the resulting BN offers explainable and quantitative predictions on a range of variables of interest, including the diagnosis of bacterial pneumonia, detection of respiratory pathogens in the nasopharynx, and the clinical phenotype of a pneumonia episode. Satisfactory numeric performance has been achieved including an AUROC of 0.8 in predicting the clinical diagnosis of bacterial pneumonia. Three commonly encountered scenarios were presented to demonstrate the potential usefulness of the BN outputs in various clinical pictures.
Conclusions To our knowledge, this is the first causal model developed to help determine the causative pathogen for paediatric pneumonia. It can be utilized to derive recommendations to support more directed and judicious use of antimicrobials for relevant cohorts. The BN needs further validation before it can be clinically implemented. Our model framework and the methodological approach can be adapted beyond our context to broad respiratory infections and geographical and healthcare settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by Perth Children Hospital Foundation (Grant ID 9900). YW is supported by the Western Australian Health Translation Network Early Career Fellowship and the Australian Government's Medical Research Future Fund (MRFF) as part of the Rapid Applied Research Translation program. CCB is supported by an Investigator grant from the National Health and Medical Research Council (NHMRC, APP1173163). TS is supported by a NHMRC Career Development Fellowship (GNT1111657). LK is supported by a Perron Foundation fellowship and NHMRC Ideas Grant (APP2003876). AOM is supported by a NHMRC Postgraduate Scholarship (APP1191465) and an Australian Government Research Training Program Fees Offset. CM is supported by a RAINE Clinician Research Scholarship. PCMW is supported by a NHMRC Investigator grant (APP1197335).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Child and Adolescent Health Service Human Research Ethics Committee of Perth Children's Hospital gave ethical approval for this work (RGS2477).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Typos fixed, including 'receiver-operating characteristics curve', 'practice', etc. Units of temperature, CRP, WCC, respiratory rate clarified in both main manuscript and Additional File 2. Additional File 1, Survey 4 updated, with model version number clarified.
Data Availability
All data produced in the present study are available upon reasonable request to the authors, the source BN model with associated dictionary can be accessed via Open Science Framework at https://osf.io/m97vb/.
